Condition
Advanced Endometrial Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Advanced Endometrial Cancer clinical trials that are recruiting, at sites in 3 countries (most in China (3), United States (1), United Kingdom (1)). By phase: Phase 1 (2), Phase 3 (1), Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Advanced Endometrial Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| OPB-201 therapy for recurrent endometrial and platinum-resistant ovarian cancer | Phase 1 | San Francisco, California and 4 other locations | Recruiting | Jun 24, 2026 |
| Evaluating HB0025 Injection for Advanced Solid Tumors | Phase 1/2 | Baoding, Hebei and 13 other locations | Recruiting | Jan 3, 2025 |
| Combining fruquintinib and sintilimab for advanced endometrial cancer treatment | Phase 3 | Beijing, Beijing Municipality and 16 other locations | Recruiting | Sep 4, 2024 |
| MOv18 IgE treatment for platinum-resistant ovarian cancer | Phase 1 | Bristol and 6 other locations | Recruiting | Aug 9, 2024 |
| Treatment of advanced endometrial cancer with Envafolimab and Lenvatinib | Phase 2 | Beijing, Beijing Municipality and 18 other locations | Recruiting | Nov 9, 2021 |
All recruiting trials (5)
-
OPB-201 therapy for recurrent endometrial and platinum-resistant ovarian cancer
A one-time treatment with a patient’s own T cells engineered to target PRAME is being tested to see if it is safe and what dose works best for adults with recurrent endometrial cancer or platinum-resistant ovarian cancer.
-
Evaluating HB0025 Injection for Advanced Solid Tumors
This study is testing a new injection called HB0025 combined with chemotherapy to see if it can help people with advanced lung or endometrial cancer feel better and improve their treatment outcomes.
-
Combining fruquintinib and sintilimab for advanced endometrial cancer treatment
This study is testing if a new combination of fruquintinib and sintilimab can help people with advanced endometrial cancer who didn't respond to their first treatment feel better compared to standard chemotherapy.
-
MOv18 IgE treatment for platinum-resistant ovarian cancer
This study is testing a new treatment called MOv18 IgE for people with platinum-resistant ovarian cancer to see if it can help shrink tumors and improve their health.
-
Treatment of advanced endometrial cancer with Envafolimab and Lenvatinib
This study is testing if a new treatment combining Envafolimab and Lenvatinib can help people with advanced endometrial cancer who haven't had success with regular chemotherapy.
Related topics
Quick answers
How many Advanced Endometrial Cancer clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (3 trials), United States (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 3: 1, Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.